Publications by authors named "Vanessa Rowe"

Claim this Profile
R
Resistant Blood Pressure: New Frontiers in Interventional Hypertension Therapy.
Jeffrey D Taylor, Chukwunonyelum Uche, Vanessa Rowe, Aleyah Hattab, Arvind Draffen

Cardiol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of motor affordances in immediate and long-term retention of objects.
Katherine Guérard, Marie-Claude Guerrette, Vanessa P Rowe

Acta Psychol (Amst)· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble lymphotoxin is an important effector molecule in GVHD and GVL.
Kate A Markey, Angela C Burman, Tatjana Banovic, Rachel D Kuns, Neil C Raffelt, Vanessa Rowe

Blood· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration.
Rachel D Kuns, Edward S Morris, Kelli P A Macdonald, Kate A Markey, Helen M Morris, Vanessa Rowe

Blood· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation.
Edward S Morris, Kelli P A MacDonald, Rachel D Kuns, Helen M Morris, Tatjana Banovic, Vanessa Rowe

Nat Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract.
Angela C Burman, Tatjana Banovic, Rachel D Kuns, Andrew D Clouston, Amanda C Stanley, Vanessa Rowe

Blood· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD.
Kelli P A MacDonald, Rachel D Kuns, Vanessa Rowe, Edward S Morris, Tatjana Banovic

Blood· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation.
Vanessa Rowe, Tatjana Banovic, Kelli P MacDonald, Rachel Kuns, Alistair L Don

Blood· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.
Edward S Morris, Kelli P A MacDonald, Vanessa Rowe, Tatjana Banovic, Rachel D Kuns

J Clin Invest· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-beta in allogeneic stem cell transplantation: friend or foe?
Tatjana Banovic, Kelli P A MacDonald, Edward S Morris, Vanessa Rowe, Rachel Kuns

Blood· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion.
Kelli P A MacDonald, Vanessa Rowe, Helen M Bofinger, Ranjeny Thomas, Tedjo Sasmono

J Immunol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells.
Kelli P A MacDonald, Vanessa Rowe, Andrew D Clouston, Joseph K Welply, Rachel D Kuns

J Immunol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
Kelli P A MacDonald, Vanessa Rowe, Cheryl Filippich, Diana Johnson, Edward S Morris

Biol Blood Marrow Transplant· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance.
Edward S Morris, Kelli P A MacDonald, Vanessa Rowe, Diana H Johnson, Tatjana Banovic

Blood· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
Kelli P A MacDonald, Vanessa Rowe, Cheryl Filippich, Ranjeny Thomas, Andrew D Clouston

Blood· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis